Carregant...
Dose Escalation of an Evans Blue Modified Radiolabeled Somatostatin Analogue (177)Lu-DOTA-EB-TATE in the Treatment of Metastatic Neuroendocrine Tumors
PURPOSE: To evaluate the safety and efficacy of (177)Lu-DOTA-EB-TATE, a radiolabeled somatostatin analogue modified by Evans Blue, at escalating doses, to increase tumor retention in patients with progressive metastatic neuroendocrine tumors (NETs). METHODS: Thirty-three patients with metastatic NET...
Guardat en:
| Publicat a: | Eur J Nucl Med Mol Imaging |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7080608/ https://ncbi.nlm.nih.gov/pubmed/31832728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04530-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|